Donald Richards, MD
Enriched profileMedical Oncology, Hematology (specialty line on profile) · Texas Oncology-Tyler
Donald Richards is Medical Oncology, Hematology (specialty line on profile) at Texas Oncology-Tyler. ClinicalTrials.gov lists 8 registered studies with this person as an investigator.
Data verified 27 Oct 2026
Overview
Updated 27 Oct 2026
Donald Richards, MD, is Medical Oncology, Hematology (specialty line on profile) at Texas Oncology-Tyler. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 33 companies.
- Top research focus: Gastroesophageal Cancer
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 33 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Sponsor: Eli Lilly and Company
Industry payments
Updated 27 Oct 2026
33 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Janssen Global Services, LLCProgram year20251 payment
- Galvanize Therapeutics, IncProgram year20251 payment
- ABBVIE INC.Program year20255 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
48.5%PD-1 inhibitor21.3%Pembrolizumab100%Part B, office-administered≥28 patientsMicrotubule Inhibitor14.9%Paclitaxel100%Part B, office-administered≥33 patients+ 11 more classes in this area
Blood & clotting
22.5%Parenteral Iron Replacement12.6%Iron sucrose100%Part B, office-administered≥21 patientsErythropoiesis-stimulating Agent9.8%Darbepoetin alfa100%Part B, office-administered≥13 patients+ 2 more classes in this area
Metabolism & gastrointestinal
14.8%Other antiemetics11.7%Fosaprepitant100%Part B, office-administered≥30 patientsSerotonin-3 Receptor Antagonist2.6%Palonosetron hcl57%Granisetron hydrochloride39%Ondansetron Odt3%Ondansetron Hcl1%Part D + Part B<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 27 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
texasoncology.com/doctors/donald-richards
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →texasoncology.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D. (medical doctorate)
University of Texas Health Science Center, San Antonio
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗ - Ph.D. in Cell Biology
Baylor College of Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗
Editorial & leadership roles
journal and society appointments- Member
GI Cancer Committee, The US Oncology Network
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗ - Member
Translational Oncology Program, The US Oncology Network
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗ - Member
Pancreatic Cancer Research Team
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗ - Member
American Society of Clinical Oncology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗ - Member
Smith County Medical Society
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗ - Member
Texas Medical Association
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →texasoncology.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medifind.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH